Keyphrases
Migraine
99%
Pediatric Headache
67%
Headache
45%
Pediatric Patients
41%
Headache Clinic
40%
Retrospective Cohort Study
27%
Allodynia
21%
Tension-type Headache
17%
Nontuberculous Mycobacterial Lymphadenitis
16%
Novel mutation
16%
Adolescent Patients
16%
Infantile Spasms
16%
Ceftriaxone
16%
Cutaneous Allodynia
16%
Migraine without Aura (MWoA)
15%
Pediatric Population
15%
Pertussis
14%
Lymphadenitis
14%
Head Trauma
14%
Mycobacterium Tuberculosis (M. tb)
14%
Clinical Parameters
13%
Pediatric
13%
Mycobacterium Haemophilum
13%
Medical Files
13%
Electroencephalogram
12%
Vomiting
10%
Visual Loss
10%
Non-pharmacological Treatment
10%
Migraine Treatment
10%
Chronic Abdominal Pain
10%
Shigellosis
10%
Comparative Efficacy
10%
Chronic Kidney Disease
10%
Thunderclap Headache
10%
Migraine Headache
9%
Magnetic Resonance Imaging
9%
Age of Onset
9%
Electroencephalography
9%
Young children
8%
Immunocompetent child
8%
Pharmacological Therapy
8%
Young Age
8%
Blunt Head Trauma
8%
Scar
7%
Thunderclap
7%
Israel
7%
Age Groups
7%
Pertussis Infection
7%
Short Stature
7%
Obesity
7%
Medicine and Dentistry
Pediatrics
100%
Migraine
95%
Headache
90%
Adolescent
31%
Lymphadenitis
27%
Symptom
23%
Pediatrics Patient
22%
Retrospective Cohort Study
21%
Allodynia
21%
Closed Head Injury
18%
Disease
17%
Tension Headache
17%
Prevalence
15%
Magnetic Resonance Imaging
12%
Mycobacterium haemophilum
12%
Abdominal Pain
10%
Visual Impairment
10%
Thunderclap Headache
10%
Infantile Spasm
10%
Chronic Kidney Disease
10%
Atypical Mycobacterium
10%
Toddlers
7%
Infection
7%
Onset Age
7%
Short Stature
7%
Lymph Node
7%
Drug Megadose
6%
Emergency Department
6%
Optic Nerve
6%
Childhood Obesity
6%
Physical Examination
6%
Family History
6%
Cohort Analysis
6%
Pathogen
5%
Thrombophilia
5%
Lymphedema
5%
Enuresis
5%
Posttraumatic Stress Disorder
5%
Cerebrospinal Fluid Pressure
5%
Baby Colic
5%
Arachnoid Cyst
5%
Hydrocephalus
5%
Acute Lymphoblastic Leukemia
5%
Toxocariasis
5%
Argininemia
5%
Subarachnoid Space
5%
Glucocorticoid
5%
Platelet
5%
Facial Nerve Paralysis
5%
Sequela
5%